Press Release: The
@IASLC
names four multidisciplinary international doctors as Co-Chairs of IASLC 2024 World Conference on Lung Cancer (
#WCLC24
). Read More:
#LCSM
Today is Day 1 of Lung Cancer Awareness Month 2022 (
#LCAM22
). Fact: Did you know that
#LungCancer
causes more deaths globally than colon, breast, & prostate cancers combined?
#LCSM
The
#WCLC20
is going virtual! The
@IASLC
will provide a comprehensive virtual program that delivers the knowledge and networking-rich conference to the global thoracic oncology community from January 28-31, 2021. Register now at
The passion and dedication of the global
#lungcancer
community never ceases to amaze, and this year's
#WCLC19
was no different. Thank you to all who joined us this year in
#Barcelona
. We hope to see you again next year for
#WCLC20
!
#LCSM
#Hope
Congratulations to the 2021
@IASLC
Cancer Care Team Award Winners who offer exceptional care to patients with lung cancer every day. This award recognizes the best teams, as nominated by the patients they serve.
Amazing presentation at
#WCLC2018
Presidential Symposium of NELSON mortality results. A wonderful result showing a substantial reduction in
#lungcancer
mortality in both genders.
#LCSM
#EarlyDetection
It's time for CASPIAN results. Wonderfully delivered by Dr. Luis Paz-Ares, the study shows that durvalumab + cisplatin- or carboplatin-etoposide in ES-SCLC provides an important new treatment option for patients and physicians.
#LCSM
#SCLC
#WCLC19
The Board of Directors of the
@IASLC
is pleased to announce the appointment of Karen L. Kelly, M.D. to the position of Chief Executive Officer, effective Spring 2022. Read more about Dr. Kelly's expertise & involvement here:
Congratulations to Dr. Tasuku Honjo on a well-deserved
#nobelprize
for pioneering contributions to
#immunotherapy
that have given new hope to cancer patients. We were lucky to hear Dr. Honjo speak at
#WCLC2017
. Watch Dr. Honjo’s summary of his talk.
#LCSM
Congratulations to Dr. Charles Rudin of
@sloan_kettering
for winning the
#WCLC19
Paul A. Bunn, Jr. Scientific Award, which recognizes his lifetime achievement in sci. contributions to
#thoraciccancer
research.
#LCSM
Gain new perspectives from the world’s leading medical oncologists, researchers & thought leaders at
#WCLC2018
. Access a dynamic educational program composed of 2000+ oral and poster presentation.
Analysis of overall survival data from the IMpower010 trial shows overall survival trend in favor of atezolizumab in the PD-L1 TC > 1% stage II-IIIA population but not in the all randomized stage II-IIIA or intent-to-treat population per research presented today at
#WCLC22
.
#LCSM
At
#WCLC22
@peters_solange
presents research from the POSEIDON trial showing patients w/ metastatic
#NSCLC
who received tremelimumab+durvalumab +chemo experienced longer survival compared with those who received chemotherapy alone, regardless of STK11, KEAP1 or KRAS status.
Thank you,
#Toronto
! The IASLC 19th Conference on Lung Cancer came to a close today. We’ve enjoyed our time in this great city. See you in 2019 in Barcelona!
#WCLC2018
#LCSM
#lungcancer
An optimistic new study published in the
@JTOonline
, our official journal, shows that median survival for stage IV ALK+
#lungcancer
is now at 6.8 yrs when the right care is received. While much work remains to be done, this is real progress.
#LCSM
Researchers have found two new radiomics features that occur in and around
#lungcancer
tumors and can be used to identify patients that are at risk for poor survival outcomes. This research was presented last week at
#NACLC19
.
#LCSM
Collaborate with 7,000+ clinicians, researchers & scientists in the shared goal of conquering lung cancer at the IASLC 2019 World Conference on Lung Cancer. Abstract submissions end on April 10, 2019.
Submit your abstract -->
#LCSM
#LungCancer
#WCLC19
Potentially practice-changing studies will be presented at our WCLC 2020 Virtual Presidential Symposium on 8/8/20, serving as a prelude to our
#WCLC20
meeting (1/26-1/29, 2021). Interact with your peers and engage in real-time Q&A. Registration details coming soon!
#LCSM
We've released an official policy statement on electronic cigarettes that strongly discourages their use by youth or by adults who are not currently smoking.
#LCSM
Don’t miss your opportunity to see up to 2,600 presentations on lung cancer and thoracic oncology at the IASLC 2019 World Conference on Lung Cancer.
Register today -->
Early bird discounts ends June 7, 2019
#LCSM
#LungCancer
#WCLC19
Tomorrow is the start of Lung Cancer Awareness Month (
#LCAM
). Visit for information on how to get involved. Read the stories of survivors and caregivers; find helpful resources; and share your own experience with this disease.
#LCSM
#HopeLives
Lung cancer advocate Fredrik Johansson received a standing ovation following his talk about the patient’s perspective. Diagnosed at age 35 with stage IV
#lungcancer
, 4.5 years later he hopes for “a better public understanding of what lung cancer is”
#ELCC18
#LCSM
We're excited to announce the chairs for our 2021 World Conference on Lung Cancer (
#WCLC21
) will be Drs. David Harpole,
@KHigginsMD
and Thomas Stinchcombe. We can't wait to work closely with this group of
#lungcancer
leaders to bring you another extraordinary meeting.
#LCSM
After considering the latest
#coronavirus
updates, the IASLC leadership has postponed
#WCLC20
to Jan. 26-29, 2021, in Singapore. For all questions, please review our postponement FAQ: . Thank you for understanding during this difficult time.
#LCSM
#COVID19
We've issued a statement on lung cancer screening with low-dose computed tomography (LDCT) based on results from the Dutch-Belgian NELSON lung cancer screening trial presented at
#WCLC2018
.
#LCSM
#EarlyDetection
Join the global lung cancer community this year in Barcelona for
#WCLC19
. We're pleased to be able to once again offer funding to help patients and advocates attend the meeting. Apply by April 17!
#LCSM
"Sharp fall in mortality from
#NSCLC
in the US is most likely due to biomarker testing, precision medicine and targetedtherapies. With the more recent benefit seen with immunotherapy we will probably see a further decline"- Chandra Belani, CSO IASLC.
#LCSM
A large international study of patients with
#NSCLC
tumors that are two centimeters or less, found that sub lobar surgery was non-inferior to lobectomy, according to results presented today at
#WCLC22
.
#LCSM
Dr. Jessica Lin describes the best sequence for
#ALK
&
#ROS1
inhibitors at
#NACLC22
. She says ALK and ROS1 fusion-positive lung cancers represent disease subsets in which we have highly-effective targeted therapies available.
We're proud to bring together such an incredible array of talented experts under one roof. Thank you Dr. Lovly for sharing these updates!
#LCSM
#TTLC20
Women with potential symptoms of
#lungcancer
are often not suspected by their primary care providers, resulting in potential delays in referrals and diagnosis...
#LCAM23
#IASLC
The
@IASLC
is pleased to announce the newly-elected 2023 BOD Members. President-Elect, Caicun Zhou; Board Members: Drs.
@bensolomon1
, Wen-Zhao Zhong, Antoni Rosell, Natasha Leighl, Ignacio Wistuba, and
@JoeChangMD
Their term begins at the upcoming
#WCLC23
.
Our team is on the ground in Toronto for
#WCLC2018
, and we can't to welcome YOU to the world's largest meeting dedicated solely to
#lungcancer
. Be sure to stop by the Social Media Booth on level 300 to take a picture with our Niagara Falls backdrop. Enjoy the conference!
#LCSM
.
@rocketgirlmd
delivers a thoughtful, complex and touching talk at
#WCLC2018
on her late husband, Paul, their experience when he became afflicted w/ cancer and the resilience/power that comes when human beings cultivate a sense of meaning in their lives. Thank you Lucy!
#LCSM
Globally
#lungcancer
in never smokers is on the rise, especially in E. Asia. At
#ACLC22
Dr. Gee-Chen Chang describes the distinct distribution of patients by gender in E. Asia, Europe & US & the proteogenomics of demographically distinct early lung adenocarcinomas & progression.
A warm congratulations to
@DrRoyHerbstYale
. Welcome to the IASLC Board of Directors! Our organization will surely benefit from your vision, leadership and expertise.
#LCSM
First-line Keytruda improves survival for non-small cell lung cancer: Phase 3 of KEYNOTE-042 trial of pembrolizumab (Keytruda) met its primary endpoint of OS for first-line treatment of patients w/locally advanced or metastatic
#NSCLC
w/PD-L1 expression
The risk of second
#LungCancer
remains as high among never smokers as ever smokers, once an individual is survived from initial
#LungCancer
. A targeted surveillance strategy is needed for lung cancer survivors who never smoked, analyzed by
@AEunjiChoi
& team.
#LCSM
#NACLC22
🎉The
#IASLC
turns 50, join the celebration! We are grateful for our visionary founders/members/partners during our journey.Cheers to all for achieving this milestone together! Let's keep conquering
#lungcancer
worldwide in the 21st century!
#IASLC50
#LCSM
“Advocates who are knowledgeable about the science of lung cancer are better prepared to share the patient perspective and accelerate research."
The IASLC STARS program seeks to train advocates in the science of
#lungcancer
. Apply by 5/1.
#LCSM
Today, as we acknowledge and celebrate
#WorldLungCancerDay
, we continue our mission to spread awareness, provide education and use all available means to eliminate lung cancer and thoracic malignancies worldwide.
#LCSM
#Hope
#NoStigma
“If Lung Cancer Causes 32% of All Cancer Deaths. Why Does It Get 10% of Research Funding?” - New commentary in
@FortuneMagazine
by our CEO, Fred Hirsch, and our Foundation Board Member
@KWebFight
.
Lung cancer is a complex disease w/many causes; Largely overlooked is the relationship between air pollution &
#lungcancer
. We support advocacy for clean air & urge health care organizations & relevant legislative bodies to support our policy statement:
It's midday here at the IASLC 2019 World Conference on Lung Cancer (
#WCLC19
), and we just caught up with the conference's co-president, Dr. Ramon Rami-Porta, who welcomed all attendees to both the WCLC and the beautiful city of
#Barcelona
.
#LCSM
Gain insights from global leaders on lung cancer at the IASLC 2019 World Conference on Lung Cancer (WCLC 2019) in Barcelona, Spain from September 7 – 10, 2019.
Register today -->
Early bird savings end June 7, 2019.
#LCSM
#LungCancer
#WCLC19
Early detection can save lives. Exciting to see this recent announcement by
@NHSEngland
of a "multimillion pound program of targeted lung health checks, rolling out in ten of the most deprived regions in the country."
#LCSM
#LungCancer
The IASLC Presidential Symposium, featuring the top seven abstracts of the conference, is starting soon. Be sure to get to the plenary hall early to grab a seat! You won't want to miss the unveiling of some of the biggest science of the year!
#CancerResearch
#LungCancer
#LCSM
The election results are in, and we're excited to announce that
@HwakeleeMD
has been named the president-elect of the IASLC Board of Directors! Dr. Wakelee will be joined by new BOD members
@DrRoyHerbstYale
,
@DrBezjakRO
, Erik Thunnissen and Caicun Zhou. Congratulations!
#LCSM
Get the facts on
#COVID19
from the experts in the latest "Lung Cancer Considered." In this eps., advocate
@JFreemanDaily
is joined by Drs. Amy Moore, Upal Basu Roy and
@LeciaSequist
for an in-depth discussion on the pandemic's impact.
#LCSM
#Coronavirus
Today is
#NationalDoctorsDay
, and as an association of more than 8,500 lung cancer specialists, we want to thank all of our selfless health care providers for their extraordinary efforts to provide excellent patient care - both during this current crisis and every day.
#LCSM
Congratulations to Dr. Cecile Le Pechoux for receiving the 2021 James D. Cox Lectureship Award for Radiation Oncology. Award winners are selected by the
@IASLC
Advance Radiation Tech. Committee & were presented at the
#WCLC21
. Learn more: .
@GustaveRoussy
Registration is now open for the IASLC 2020 World Conference on Lung Cancer (
#WCLC20
), our biggest event of the year!
Learn more and make your plan to join us in Singapore for the world's largest conference dedicated solely to thoracic cancers.
#LCSM
“Clinical trials are no longer a last-resort option for patients with lung cancer. Every patient should have hope and equal access to clinical trials.”
@JFreemanDaily
#VPS20
#LCSM
#WCLC20
This World Lung Cancer Day, you can inspire hope through research with a donation to the International Lung Cancer Foundation.
#WorldLungCancerDay
#ILCF
In EGFR-mutant
#lungcancer
@politikaterina
asked “How can we get as close to a cure as possible?” On her list: improving & increasing models & studying longitudinal biopsies. She also acknowledged patient advocates’ work & their value to the lung cancer community
#TTLC19
#LCSM
Our World Conferences often unveil exciting new developments within the IASLC - and this year is no different. We’re pleased to welcome Drs. Herbst, Bezjak, Zhou and Thunnissen as official new BOD members - as well as Dr. Wakelee as president-elect. Welcome!
#WCLC19
#LCSM
#Lungcancer
is the most common cause of cancer death, and kills more women than breast, ovarian, uterine & cervical cancers, combined...
#LCAM23
#IASLC
We are excited to share with you the preliminary program for the IASLC WCLC 2020: Virtual Presidential Symposium on August 8, 2020. Registration for this exclusive event is complimentary.
#IASLC
#LungCancerResearch
#IASLCWCLC2020
A study presented by
@alexandra_p_24
&
@chifujeffyang
questions the adequacy of Pack-Year Smoking History in determining
#lungcancer
screening eligibility. Their findings suggest that proposed guidelines could address racial disparities, promoting a more equitable approach to
Welcome attendees to the 2019 World Conference on Lung Cancer (
#WCLC19
). From everyone at the IASLC, we're delighted you've joined us here in
#Barcelona
for four days of science, education, collaboration and hope in a beautiful city.
#LCSM
Lung specialists can ease fear & confusion felt by patients about CT-detected lung nodules by using a simple 3D model that explains sizes & textures of lesions & their associated Lung-RADS scores. Learn why & how the model was created in this ILCN article.
Anyone with lungs can get lung cancer. Worldwide, ~20% of men with lung cancer are non-smokers while over 50% of women with lung cancer are non-smokers.
#LCAM23
#LCSM
Congratulations to Dr. Trudy Oliver for receiving the 2021 Heine H. Hansen Lectureship Award for Small Cell Lung Cancer. Award winners are selected by the
@IASLC
Nominating Committee & were presented at the
#WCLC21
. Learn more: .
@huntsmancancer
The new "Lung Cancer Considered" focuses on the ADAURA trial from
@ASCO
2020. The episode features a conversation between
@IASLC
CSO, Dr. Chandra Belani, Dr. Nathan Pennell, Dr. Jack West and Jill Feldman, a lung cancer patient & advocate. Listen now at
The latest "Lung Cancer Considered" discusses the virtual
@ASCO
Annual meeting, how conferences will be structured during
#COVID19
and the power of social media during a pandemic. Featuring a conversation between
@JackWestMD
and
@tmprowell
.
#LCSM
National Lung Screening Trial follow-up confirms low-dose CT reduces
#lungcancer
deaths, with results published in
@JTOonline
. Commenting on the study. Dr. Pinsky stated, "This study adds further weight to the notion that CT screening is effective."
#LCSM
We are pleased to announce that the
@JTOonline
has an updated impact factor of 13.357, up from 12.460 in 2018! This accomplishment now ranks the JTO 11th of 244
#oncology
journals and 3rd of 64 respiratory journals! Read the entire release here:
#LCSM
It's Friday and we have big news. Developed w/
#lungcancer
advocates and patient advocacy nonprofits, we're proud to introduce a new initiative: Supportive Training for Advocates on Research and Science (STARS).
#LCSM
#Advocacy
#FridayFeeling
Learn more:
Listen to a fantastic conversation between
@NarjustDumaMD
,
@Tony_Calles
and
@drcoronacruz
in the latest "Lung Cancer Considered." This Spanish language eps. focuses on telemedicine and how patients can find information in different global regions.
#LCSM
The room is buzzing as attendees settle in for the Presidential Symposium at
#WCLC2018
. Presentations on the top five abstracts of the conference are coming up soon!
#LCSM
#CancerResearch
#LungCancer
The
@US_FDA
has approved durvalumab (IMFINZI®, AstraZeneca) in combination with etoposide and either carboplatin or cisplatin as first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC).
#LCSM
#SCLC
The IASLC supports the recommendations from the USPSTF to lower the age to start lung cancer screening and to reduce the minimum number of pack years of cigarette smoking to recommend screening.
#LCSM